A new kid on the block: PKD1: a promising target for antiangiogenic therapy?

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1689-90. doi: 10.1161/ATVBAHA.108.174250.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism*
  • Humans
  • Matrix Metalloproteinase 10 / metabolism
  • Matrix Metalloproteinase 14 / metabolism
  • Neovascularization, Physiologic / drug effects*
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Protein Kinase Inhibitors / pharmacology*
  • Signal Transduction / drug effects*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Protein Kinase Inhibitors
  • Vascular Endothelial Growth Factor A
  • protein kinase D
  • Protein Kinase C
  • MMP10 protein, human
  • Matrix Metalloproteinase 10
  • MMP14 protein, human
  • Matrix Metalloproteinase 14
  • HDAC7 protein, human
  • Histone Deacetylases